Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis
US8741923B2 · kind B2 · utility
0Cited by
5References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 15, 2009 |
| Grant date | Jun 3, 2014 |
| Priority date | — |
| Expiry date | Jun 22, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compounds of Formula (I) for the treatment of multiple sclerosis and other diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.